CASI PHARMACEUTICALS, INC. (CASIF) Free cash flow 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$20.8MFY2025 · since FY2020: -$27.4M → -$20.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.8M | +29.5% |
| FY2024 | -$29.4M | -46.0% |
| FY2023 | -$20.2M | +24.5% |
| FY2022 | -$26.7M | +25.4% |
| FY2021 | -$35.8M | -30.7% |
| FY2020 | -$27.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice